Kenneth C. Frazier is Executive Chairman of Merck’s board of directors, after stepping down as CEO on July 1, 2021. He previously served as President and Chief Executive Officer since 2011.
Under Ken’s leadership, Merck delivered innovative lifesaving medicines and vaccines as well as long-term and sustainable value to its multiple stakeholders. Ken substantially increased Merck’s investment in research, including early research, while refocusing the organization on the launch and growth of key products that provide far-reaching benefits to society. He also led the formation of philanthropic and other initiatives that build on Merck’s 130-year legacy.
Ken joined the company in 1992 and held positions of increasing responsibility, including General Counsel and President. Prior to joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath. Ken’s contributions, especially in the legal, business, and humanitarian fields, have been widely recognized. He sits on the boards of PhRMA, Weill Cornell Medicine, Exxon Mobil Corporation, Catalyst, the National Constitution Center, and Cornerstone Christian Academy in Philadelphia, PA. He is co-founder and co-chair of OneTen, a coalition of leading organizations committed to upskilling, hiring, and promoting one million Black Americans into family-sustaining jobs. OneTen is committed to facilitating a meaningful, measurable, and lasting impact on racial and economic justice. Ken also is a member of the American Academy of Arts and Sciences, the American Philosophical Society, The Business Council, the Council of The American Law Institute, the American Bar Association, and a Fellow of the College of Physicians of Philadelphia. Additionally, Ken is co-chair of the Legal Services Corporation’s Leaders Council.
As a strong advocate for social justice and economic inclusion, Ken is the recipient of numerous awards and honors, including the Anti-Defamation League Courage Against Hate Award, the Botwinick Prize in Business Ethics from Columbia Business School, the Legend in Leadership Award from the Yale School of Management, the NAACP Legal Defense and Educational Fund National Equal Justice Award, and the National Minority Quality Forum’s Lifetime Achievement Award. In 2018, Ken was named one of the World’s Greatest Leaders by Fortune magazine and also was named one of TIME’s 100 Most Influential People. In 2019, he became the first recipient of the Forbes Lifetime Achievement Award for Healthcare. In 2021, his peers named Ken Chief Executive magazine’s CEO of the Year.
EDUCATION: Penn State University, B.A.; Harvard Law School, J.D.